William P. Sheridan, Chief Medical Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 320,878 shares at $16.87 ($5.4M) on 2022-03-10, disclosed to the SEC on 2022-03-14.
Seasonal sale ($5.4M) by Chief Medical Officer — this insider has traded BCRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.87 | 159,739 | $2.7M | 49.8% |
| 2 | $16.87 | 159,739 | $2.7M | 49.8% |
| 3 | $17.64 | 1,400 | $25K | 0.5% |
| Total | $16.87 avg | 320,878 | $5.4M | 100% |
| Filing → |
| BCRX | SELL | 2018-12-20 | $311K | — | Filing → |
| BCRX | SELL | 2018-08-13 | $439K | — | Filing → |
| BCRX | SELL | 2018-06-05 | $531K | — | Filing → |